Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy

Esophageal cancer (EC) has a high incidence and poor prognosis. The two major histological types, squamous cell carcinoma and adenocarcinoma, differ in their epidemiology and treatment options. Patients with locally advanced EC benefit from multimodal therapy concepts including neoadjuvant chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Feng, Xijia, Li, Chengqiang, Lerut, Toni, Li, Hecheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771193/
https://www.ncbi.nlm.nih.gov/pubmed/36525602
http://dx.doi.org/10.1097/CM9.0000000000002371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771193/
https://www.ncbi.nlm.nih.gov/pubmed/36525602
http://dx.doi.org/10.1097/CM9.0000000000002371

Ejemplares similares